Navigation Links
Memory Pharmaceuticals Granted Extension to Comply with NASDAQ Listing Requirements
Date:10/31/2008

MONTVALE, N.J., Oct. 31 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY) today announced that the NASDAQ Listing Qualifications Panel has granted the Company's request for an extension until December 3, 2008 to comply with the NASDAQ Capital Market minimum market capitalization requirement of $35 million or the alternative requirement of $2.5 million in stockholders' equity in order to remain listed. There can be no assurance that the Company will achieve compliance by the specified deadline.

About the Company

Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on developing innovative drugs for the treatment of debilitating CNS disorders, many of which exhibit significant impairment of memory and other cognitive functions, including Alzheimer's disease and, schizophrenia. For additional information, please visit our website at http://www.memorypharma.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties. All statements, other than statements of historical facts, regarding management's expectations, beliefs, goals, plans or Memory Pharmaceuticals' prospects, future financial position, future revenues and projected costs should be considered forward-looking. Readers are cautioned that actual results may differ materially from projections or estimates due to a variety of important factors, including the outcome of clinical trials of Memory Pharmaceuticals' drug candidates and whether they demonstrate these candidates' safety and effectiveness; the risks and uncertainties asso
'/>"/>

SOURCE Memory Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Gladstone scientists uncover potential mechanism of memory loss in Alzheimers disease
2. Scientists synthesize memory in yeast cells
3. Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster
4. Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster
5. Scientists synthesize memory in yeast cells
6. Amarin Announces Publication of Pre-Clinical Memory Data in Journal of Neurochemistry
7. BioMedical Enterprises, Inc. (BME) Receives FDA Clearance for Spine Use of Its Memory Metal Implants
8. ASU researchers improve memory devices using nanotech
9. Memory Pharmaceuticals to Announce Third Quarter Results on Thursday, November 8, 2007
10. Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 3454 in Cognitive Impairment Associated with Schizophrenia
11. Amarin to Commence Phase II Trial With AMR101 in Age Associated Memory Impairment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... Toronto, Ontario (PRWEB) May 22, 2013 ... of advanced sound therapy for tinnitus treatment. AudioNotch ... Destination Hearing . With clinic locations in both ... trusted provider of audiology and hearing services. AudioNotch's ... Zabell locations. , Upon entering a Destination Hearing ...
(Date:5/22/2013)... Express Diagnostics Int’l, Inc. (EDI) ... are pleased to announce a sponsorship agreement with Erebus ... Zealand distributor of DrugCheck® onsite testing devices, manufactured by ... the Austin 400 May 17-19 in Austin, Texas. , ... involves each car of the Erebus Motorsport team displaying ...
(Date:5/22/2013)... PA (PRWEB) May 22, 2013 Envera ... as Fermentation Manager. Mr. McErlean has an extensive ... of leadership positions throughout his career. , ... are very pleased to have Mike join our team”. ... installed large scale fermentation and downstream processing ...
(Date:5/22/2013)... The ability to sequence genomes has ... encode. There are now a suite of applications ... protected fragments) that dramatically expand our ability to ... Dr. Jonathan Weissman, an Investigator with the University ... Institute, who will present recent applications of their ...
Breaking Biology Technology:AudioNotch Tinnitus Treatment Launches Partnership With Destination Hearing 2Australian Distributor of Express Diagnostics Signs Sponsorship Agreement with V8 Supercar Team 2Envera Appoints Michael McErlean Fermentation Manager 2Monitoring Protein Synthesis One Codon at a Time Through Ribosome Profiling, a Webinar Hosted by Xtalks 2
... Palatin Technologies,Inc. (Amex: PTN ) will announce ... period ended March 31, 2008 before the open of,the ... Company will also conduct a teleconference and live audio ... 2008 at which they,will discuss the results of operations ...
... Bulletin Board: GNTA) today announced financial results,for the quarter ended ... has recorded significant milestones including the following:, -- ... G4544 for bone disease completes single dose-trial in 505(b)(2) ... oral taxane and new clinical-stage product ...
... Nutrition 21, Inc.,(Nasdaq: NXXI ), the developer ... Chromax(R), Advanced Memory Formula(TM) and Diabetes,Essentials(TM) -- brands ... health, enhance memory and reduce chronic joint,pain, today ... fiscal,year 2008 ended March 31, 2008., For ...
Cached Biology Technology:Palatin Technologies to Report Third Quarter, Fiscal Year 2008 Financial Results; Teleconference and Webcast on May 13th 2Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 2Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 3Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 4Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 5Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 6Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 7Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights 8Nutrition 21 Reports Fiscal Third Quarter 2008 Financial Results 2Nutrition 21 Reports Fiscal Third Quarter 2008 Financial Results 3Nutrition 21 Reports Fiscal Third Quarter 2008 Financial Results 4Nutrition 21 Reports Fiscal Third Quarter 2008 Financial Results 5Nutrition 21 Reports Fiscal Third Quarter 2008 Financial Results 6Nutrition 21 Reports Fiscal Third Quarter 2008 Financial Results 7Nutrition 21 Reports Fiscal Third Quarter 2008 Financial Results 8
(Date:5/22/2013)... The feared Legionella pneumophila bacteria is responsible ... pneumonia. In order to infect us, this pathogen has ... and go unnoticed in our cells, thus avoiding these ... the Basque biosciences research centre, CIC bioGUNE, in which ... the USA and the National Supercomputation Centre in Barcelona ...
(Date:5/22/2013)... Calif., May 22, 2013 Early screening for prostate ... pregnancy testing is for women, thanks to UC Irvine ... American Chemical Society . , After more than a ... way to clearly identify clinically usable markers for prostate ... detected far sooner, with greater accuracy and at dramatically ...
(Date:5/22/2013)... Plastic additives known as phthalates (pronounced THAL-ates) are ... up in flooring, plastic cups, beach balls, plastic ... Disease Control and Preventionthe bodies of most Americans. ... increasing scrutiny. A growing collection of evidence suggests ... packaging and mix with food) may cause significant ...
Breaking Biology News(10 mins):Mechanism discovered which aids Legionella to camouflage itself in the organism 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens 2
... Johns Hopkins infectious disease specialists who have spent more ... AIDS worldwide are warning that limited international relief supplies ... and the Caribbean will not get to those who ... an article appearing in the American Journal of Public ...
... team of researchers, led by Steven A. Rosenberg, M.D., ... Institutes of Health, have found that patients with advanced ... a significant reduction in the size of their cancers ... immunotherapy consisted of a combination of chemotherapy and reintroduction ...
... team of researchers at the Universitat Autònoma de Barcelona ... sensors have the same size and thickness as a ... chains to several minutes or a few hours, depending ... many different tasks, ranging from paternity tests and identifying ...
Cached Biology News:Hopkins AIDS experts issue warning about global efforts to provide drug therapies 2Hopkins AIDS experts issue warning about global efforts to provide drug therapies 3Hopkins AIDS experts issue warning about global efforts to provide drug therapies 4NCI Researchers Confirm the Effectiveness of Immunotherapy Approach to Treating Melanoma 2New miniaturised chip dramatically reduces time taken for DNA analysis 2New miniaturised chip dramatically reduces time taken for DNA analysis 3
... RSH-4000 is the only microplate sealer with ... long walkaway times with a variety of ... Fully automated with integrated stacker and 240-plate ... EX for use in small workcells , ...
... provides a comprehensive service for custom ... peptide microarrays synthesized on Paraflo microfluidic ... proteins/antibodies or serum samples. This comprehensive ... designs, binding assays using sample(s) provided ...
... glutathione-S-transferase (GST) is commonly used as a ... coli (1). The GSTTag sequence has been ... some cases the solubility of its fusion ... folded form, GSTTag fusion proteins can be ...
... compatible with BioTeks microplate washers, dispensers ... use and walkaway automation are guaranteed ... used with the ELx405 washer or ... small footprint fits easily in most ...
Biology Products: